These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 19879444)

  • 1. Anti-inflammatory effects of macrolides: applications in chronic rhinosinusitis.
    Harvey RJ; Wallwork BD; Lund VJ
    Immunol Allergy Clin North Am; 2009 Nov; 29(4):689-703. PubMed ID: 19879444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-inflammatory effects of macrolide antibiotics in the treatment of chronic rhinosinusitis.
    Cervin A; Wallwork B
    Otolaryngol Clin North Am; 2005 Dec; 38(6):1339-50. PubMed ID: 16326189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrolide therapy of chronic rhinosinusitis.
    Cervin A; Wallwork B
    Rhinology; 2007 Dec; 45(4):259-67. PubMed ID: 18085018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Past, present and future of macrolide therapy for chronic rhinosinusitis in Japan.
    Shimizu T; Suzaki H
    Auris Nasus Larynx; 2016 Apr; 43(2):131-6. PubMed ID: 26441370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential new avenues of treatment for chronic rhinosinusitis: an anti-inflammatory approach.
    Statham MM; Seiden A
    Otolaryngol Clin North Am; 2005 Dec; 38(6):1351-65, xi. PubMed ID: 16326190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-inflammatory effects of macrolides--an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions?
    Amsden GW
    J Antimicrob Chemother; 2005 Jan; 55(1):10-21. PubMed ID: 15590715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind, randomized, placebo-controlled trial of macrolide in the treatment of chronic rhinosinusitis.
    Wallwork B; Coman W; Mackay-Sim A; Greiff L; Cervin A
    Laryngoscope; 2006 Feb; 116(2):189-93. PubMed ID: 16467702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrolide antibiotics as immunomodulatory medications: proposed mechanisms of action.
    Shinkai M; Henke MO; Rubin BK
    Pharmacol Ther; 2008 Mar; 117(3):393-405. PubMed ID: 18289694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrolide antibiotics, bacterial populations and inflammatory airway disease.
    Swords WE; Rubin BK
    Neth J Med; 2003 Jul; 61(7):242-8. PubMed ID: 14567521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of long-term clarithromycin treatment on lavage-fluid markers of inflammation in chronic rhinosinusitis.
    Cervin A; Wallwork B; Mackay-Sim A; Coman WB; Greiff L
    Clin Physiol Funct Imaging; 2009 Apr; 29(2):136-42. PubMed ID: 19076731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What is the evidence for macrolide therapy in chronic rhinosinusitis?
    Cavada MN; Grayson JW; Sacks R
    Curr Opin Otolaryngol Head Neck Surg; 2020 Feb; 28(1):6-10. PubMed ID: 31834028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nasal polyposis: an inflammatory condition requiring effective anti-inflammatory treatment.
    Chin D; Harvey RJ
    Curr Opin Otolaryngol Head Neck Surg; 2013 Feb; 21(1):23-30. PubMed ID: 23172039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrolides beyond the conventional antimicrobials: a class of potent immunomodulators.
    Giamarellos-Bourboulis EJ
    Int J Antimicrob Agents; 2008 Jan; 31(1):12-20. PubMed ID: 17935949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrolides as immunomodulatory medications for the therapy of chronic lung diseases.
    López-Boado YS; Rubin BK
    Curr Opin Pharmacol; 2008 Jun; 8(3):286-91. PubMed ID: 18339582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of clarithromycin on nuclear factor-kappa B and transforming growth factor-beta in chronic rhinosinusitis.
    Wallwork B; Coman W; Mackay-Sim A; Cervin A
    Laryngoscope; 2004 Feb; 114(2):286-90. PubMed ID: 14755204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Medical management of chronic rhinosinusitis with macrolides].
    Górski NP; Krzeski A
    Pol Merkur Lekarski; 2005 Sep; 19(111):490-3. PubMed ID: 16358922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A progress of macrolides therapy for chronic rhinosinusitis].
    Shen S; Wang CS
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 May; 32(9):717-722. PubMed ID: 29771095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Macrolides in Chronic Rhinosinusitis (CRSsNP and CRSwNP).
    Oakley GM; Harvey RJ; Lund VJ
    Curr Allergy Asthma Rep; 2017 May; 17(5):30. PubMed ID: 28429305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maximal medical therapy for chronic rhinosinusitis.
    Lund VJ
    Otolaryngol Clin North Am; 2005 Dec; 38(6):1301-10, x. PubMed ID: 16326186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term macrolide treatment of chronic inflammatory airway diseases: risks, benefits and future developments.
    Cameron EJ; McSharry C; Chaudhuri R; Farrow S; Thomson NC
    Clin Exp Allergy; 2012 Sep; 42(9):1302-12. PubMed ID: 22925316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.